MET
MIM.164860 7q31
MET protooncogene, HGFR, RCCP2, hepatocyte growth factor/scatter factor (HGF/SF) receptor
germline mutations in familial papillary renal carcinoma (MIM.605074)
somatic mutations in sporadic papillary renal carcinoma (MIM.605074)
somatic mutations in childhood type hepatocellular carcinoma (MIM.114550)
References
Corso S, Comoglio PM, Giordano S. Cancer therapy: can the challenge be MET? Trends Mol Med. 2005 Jun;11(6):284-92. PMID: #15949770#
Dharmawardana PG, Giubellino A, Bottaro DP. Hereditary papillary renal carcinoma type I. Curr Mol Med. 2004 Dec;4(8):855-68. PMID: #15579033#
Rosario M, Birchmeier W. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 2003 Jun;13(6):328-35. PMID: #12791299#
Forum de l'article
Contact us at humpath2004@yahoo.ca if you want to be the curator of this page or this section.Copyright www.humpath.com